Comparative genomic hybridization analysis of 38 breast cancer cell lines: A basis for interpreting complementary DNA microarray data

Cancer Research

Volumn 60, Issue 16, 2000, Pages 4519-4525

  Forozan, Farahnaz ^a   Mahlamäki, Eija H ^b   Monni, Outi ^a   Chen, Yidong ^a   Veldman, Robin ^a   Jiang, Yuan ^a   Gooden, Gerald C ^a   Ethier, Stephen P ^c   Kallioniemi, Anne ^a   Kallioniemi, Olli P ^a  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF TAMPERE   (Finland)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DNA MICROARRAY; GENE AMPLIFICATION; GENE EXPRESSION REGULATION; GENE LOCATION; GENE OVEREXPRESSION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

BREAST NEOPLASMS; CHROMOSOME DELETION; DNA, COMPLEMENTARY; DNA, NEOPLASM; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION PROFILING; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; NUCLEIC ACID HYBRIDIZATION; TUMOR CELLS, CULTURED;

EID: 0034662603     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. DNA copy number amplifications in human neoplasms: Review of comparative genomic hybridization studies
2. Comparative genomic hybridization of breast tumors stratified by histological grade reveals new insights into the biological progression of breast cancer
3. Chromosome alterations in breast carcinomas: Frequent involvement of DNA losses including chromosomes 4q and 21q
4. Comparative genomic hybridisation of ductal carcinoma in situ of the breast: Identification of regions of DNA amplification and deletion in common with invasive breast carcinoma
5. Genetic alterations in lobular breast cancer by comparative genomic hybridization
6. Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer
7. Somatic genetic alterations in BRCA2 associated and sporadic male breast cancer
8. Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer
9. Positional cloning of ZNF217 and NABC1: Genes amplified at 20q13.2 and overexpressed in breast carcinoma
10. AIB 1, a steroid receptor coactivator amplified in breast and ovarian cancer
11. A putative serine/threonine kinase encoding gene BTAK on chromosome 20q13 is amplified and overexpressed in human breast cancer cell lines
12. The human CAS (cellular apoptosis susceptibility) gene mapping on chromosome 20q13 is amplified in BT474 breast cancer cells and part of aberrant chromosomes in breast and colon cancer cell lines
13. Detecting activation of ribosomal protein S6 kinase complementary DNA and tissue microarray analysis
14. Localization of PS6K to chromosomal region 17q23 and determination of its amplification in breast cancer
15. Molecular cytogenetic analysis of 11 new breast cancer cell lines
16. Quality control of CGH: Impact of metaphase chromosomes and the dynamic range of hybridization
17. A gene map of the human genome
18. Expression profiling using cDNA microarrays
19. Data management and analysis for gene expression arrays
20. Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays
21. Ratio-based decisions and the quantitative analysis of cDNA microarray images
22. Different patterns of chromosomal imbalances in metastasising and nonmetastasising primary breast carcinomas
23. Comparative genomic hybridization of ductal carcinoma in situ of the breast-evidence of multiple genetic pathways
24. Widespread chromosomal abnormalities in high-grade ductal carcinoma in situ of the breast. Comparative genomic hybridization study of pure high-grade DCIS
25. Genetic analysis of 53 lymph node-negative breast carcinomas by CGH and relation to clinical, pathological, morphometric, and DNA cytometric prognostic factors
26. Genetic aberrations in hypodiploid breast cancer: Frequent loss of chromosome 4 and amplification of cyclin D1 oncogene
27. Molecular cytogenetics of primary breast cancer by CGH
28. Comparative genomic hybridization analysis of breast tumors with predetermined profiles of DNA amplification
29. Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization
30. Comparative genomic hybridization of formalin-fixed, paraffin-embedded breast tumors reveals different patterns of chromosomal gains and losses in fibroadenomas and diploid and aneuploid carcinomas
31. The HER-2/neu oncogene: Prognostic factor, predictive factor and target for therapy
32. Tissue microarrays for high-throughput molecular profiling of tumor specimens